Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Expert Review of Gastroenterology & Hepatology|June 18, 2019
Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn studyManuel Barreiro-De Acosta, Eugeni Domènech, María Dolores Martín Arranz, et al.Gastroenterologia Y Hepatologia|January 16, 2024
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCUMar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, et al.Revista Espanola De Enfermedades Digestivas|January 16, 2024
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCUMar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, et al.Frontiers in Microbiology|January 26, 2023
Akkermansia deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient miceBeatriz López-Cauce, Marta Puerto, Juan José García, et al.Journal of Crohn'S & Colitis|February 18, 2015
Incidence, management, and course of cancer in patients with inflammatory bowel diseaseAlicia Algaba, Iván Guerra, Ignacio Marín-Jiménez, et al.Revista Espanola De Enfermedades Digestivas|November 20, 2020
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in SpainHelena Martínez-Lozano, José Miranda-Bautista, Yago González-Lama, et al.Molecular Metabolism|April 4, 2020
Impact of global PTP1B deficiency on the gut barrier permeability during NASH in miceCarmen Rubio, Marta Puerto, Juan J García-Rodríquez, et al.Scientific Reports|March 9, 2022
Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon inflammation induced by sub-chronic stressDavid Martín-Hernández, Irene L Gutiérrez, Marta González-Prieto, et al.Gastroenterologia Y Hepatologia|February 4, 2024
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative ColitisFrancisco Rodríguez-Moranta, Federico Argüelles-Arias, Joaquín Hinojosa Del Val, et al.Inflammatory Bowel Diseases|April 3, 2012
Does smoking influence Crohn's disease in the biologic era? The TABACROHN studyTiago Nunes, Maria Josefina Etchevers, Olga Merino, et al.Pageof 7